Jessica Bivins, MPHVP, Clinical Research, OneOncology
live WEBINAR
Pioneering decentralized oncology trials:
Success at the nation's largest community practices
Thursday, December 4
10 AM PT / 12 PM CT / 1 PM ET
REGISTER NOW
All registrants will be sent the webinar recording shortly following the completion of the session.
what you’ll learn
During this engaging session, you will:
- Learn how hybrid decentralized trials have been successfully launched by some of the largest research organizations in the nation
- Hear how TIME is expanding the model and adding its AI-enabled patient matching to create enrollment success.
- Hear about patient journeys supported by DCTs that allow the patient to receive care closer to home and ease the burden of research on them and sites.
SPEAKERS
READ BIO
Jessica Bivins, MPH serves as VP of Research at OneOncology, where she leads the organization’s research site management arm, OneR. OneR supports OneOncology practices in delivering clinical research within community settings, with a strong focus on expanding access to trials for diverse patient populations. As part of its innovation strategy, OneR has begun exploring decentralized clinical trial approaches.
Scott Paulson, MDDirector of Clinical Research, Texas Oncology
READ BIO
Dr. Paulson serves as the co-director of the Gastrointestinal Research Program for The US Oncology Network, as well as the medical director for the Neuroendocrine Research and Treatment Center at Baylor Charles A. Sammons Cancer Center.
Sameek Roychowdhury, MD, PhDProfessor, The Ohio State University
READ BIO
Dr. Roychowdhury is currently Professor (tenure track) of medical oncology at the Comprehensive Cancer Center and the James Cancer Hospital at The Ohio State University. His research focuses on precision cancer medicine combining genomics, computer science, novel diagnostics, biology, and clinical trials
Noelle Gaskill, MBA, ACRP-CPVP, General Manager, TIME Network, Tempus
Board Member, ACRP
Board Member, ACRP
READ BIO
Noelle Gaskill, MBA, ACRP-CP serves as the VP, GM of the TIME Network for Tempus. In her 25 years in research innovation, she has launched DCT trials in interventional oncology during her tenure in biotech.